Insider filing · ARQT
Terrie Curran
President and Chief Executive
profile →
Arcutis Biotherapeutics, Inc.
ARQT · Healthcare · 65 filings in 24 months
ticker →
Terrie Curran sold $956K of Arcutis Biotherapeutics (ARQT)
Executed Aug 27, disclosed Aug 28, 1 day later.
Value, as filed
$956K
38,200 sh across 2 lots
Executed
Aug 27
the trade date, as filed
Disclosed
Aug 28
1 day after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
TCTerrie Curran (President and Chief Executive) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Arcutis Biotherapeutics, Inc. (ARQT). The largest single filing was $956K of ARQT (38,200 sh across 2 lots, as filed), executed Aug 27.
The name
ARQTHealthcare · Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→